PET/MR scans before and after radiation for heart-lung effects
Part of Heart & circulation, Lungs & breathing clinical trials.
This study uses special PET/MR imaging before and after radiation treatment to better understand how radiation may affect the heart and lungs. It may help researchers find ways to predict and monitor these side effects using imaging and blood tests.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are age 18 or older
- You have a proven cancer mass in the chest/thorax that is planned for radiation (with or without chemotherapy)
- Your radiation plan is expected to expose part of your heart to at least 25 Gray (a dose measure)
- If you can become pregnant: you must have a negative pregnancy test within 2 weeks before the scans
- You must be able to sign consent and complete the imaging and blood test parts of the study
- You should be able to lie flat (on your back) for at least 45 minutes during scanning
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how radiation therapy to the chest affects the arteries in your heart. It uses a special PET scan (with a safe radioactive tracer) to check for early signs of inflammation or plaque buildup, which can help doctors find ways to protect your heart during cancer treatment.
This study uses a special scan (PET/CT) to look for early heart (cardiac) injury caused by radiation treatment for lung or esophageal cancer. If you may be at higher heart risk from your planned radiation dose, the scan may help researchers better measure that damage over time.
This study looks at whether PET-CT scans can help detect heart damage caused by radiation therapy in patients with stage III lung cancer. If you're getting chemotherapy and radiation together, you may participate to help doctors find ways to reduce heart risks.
This trial looks at how radiation for lung, esophageal, or breast cancer affects the heart. It may help doctors reduce heart damage in future patients.
This Phase 1 study tests a radioactive imaging agent to help doctors see disease activity in the lungs using PET/MRI scans. It includes healthy volunteers and people with lung cancer, idiopathic pulmonary fibrosis, lung transplant–related lung problems, or certain medication-related lung inflammation.
This study uses a special MRI scan with xenon gas to see how radiation therapy affects your lungs. It may help doctors better understand treatment response and side effects.
Hear when a new Pulmonary Hypertension trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.